• Explore /
  • Poster
  • / Glioma-associated antigens associated with prolonged survival in a phase I study of ICT-107 for patients with newly diagnosed glioblastoma.

Glioma-associated antigens associated with prolonged survival in a phase I study of ICT-107 for patients with newly diagnosed glioblastoma.

Abstract Poster

Authors

Surasak Phuphanich

S. Phuphanich

Neuro-Oncology Program, Cedars-Sinai Medical Center, Los Angeles, CA

S. Phuphanich , C. J. Wheeler , J. Rudnick , M. Mazer , M. Nuno , X. Fan , J. Bender , E. S. Hawkins , K. L. Black , J. Yu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT00576641

Citation

J Clin Oncol 29: 2011 (suppl; abstr 2042)

Abstract #

2042

Poster Bd #

1F

Abstract Disclosures

Similar Posters

First Author: Surasak Phuphanich

First Author: Gerald P. Linette

First Author: Wolfgang Wick

First Author: Gordana Vlahovic